Top

Published in:

01-04-2006 | Laboratory Investigation

Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma

Authors: Christopher Duntsch, Murali Krishna Divi, Terreia Jones, Qihong Zhou, Mathangi Krishnamurthy, Peter Boehm, George Wood, Allen Sills, Bob M. Moore II

Published in: Journal of Neuro-Oncology | Issue 2/2006

Title: Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma
Authors: Christopher Duntsch
Murali Krishna Divi
Terreia Jones
Qihong Zhou
Mathangi Krishnamurthy
Peter Boehm
George Wood
Allen Sills
Bob M. Moore II
Publication date: 01-04-2006
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2006
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-005-9031-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2006

Retrospective review of MEG visual evoked hemifield responses prior to resection of temporo-parieto-occipital lesions

Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells

Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma★

Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies

Therapeutic strategy for large vestibular schwannomas

A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group